Abstract
Background
The biliopancreatic diversion with duodenal switch can be performed by different combinations of restriction and malabsorption. The aim of this study was to evaluate weight loss and potential side effects for two variants of the procedure.
Methods
All patients eligible for a 2-year follow-up (n = 182) was included in the study. Thirty-five patients (group A) had a gastric remnant with a volume of approximately 200 ml, an alimentary limb (AL) of 250 cm, and a common channel (CC) of 100 cm, while 147 patients (group B) had a gastric remnant of 100–120 ml, an AL of 40%, and a CC of 10% of the small bowel length. Preoperative variables, such as body mass index (BMI), sex, age, and factors that might influence weight loss, and postoperative weight loss and side effects were registered and compared.
Results
Preoperatively, the BMI was 50.6 in group A and 52.1 in group B (ns), with no difference in age, sex, or variables that might influence weight loss. At 2 years, the BMI was 33.1 in group A (n = 34) and 28.5 in group B (n = 119) with an adjusted difference in weight loss of 5.6 BMI units between the groups (p < 0.001). Vitamin D status was also better in group B than in group A at follow-up, while there was no difference in side effects.
Conclusions
Patients with a remnant stomach of 100–120 ml, and AL and CC with individually adapted lengths had a larger weight loss and better vitamin D status postoperatively without an increase in side effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
WHO. Obesity: preventing and managing the global epidemic. Report on a WHO consultation on obesity. 2000.
Branca F, Nikogosian H, Lobstein T. The challenge of obesity in the WHO European Region and the strategies for response. 2007.
Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15(3):408–16.
Biron S, Hould FS, Lebel S, et al. Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg. 2004;14(2):160–4.
Baltasar A, Bou R, Bengochea M, et al. Duodenal switch: an effective therapy for morbid obesity—intermediate results. Obes Surg. 2001;11(1):54–8.
Tarnoff M, Kaplan LM, Shikora S. An evidenced-based assessment of preoperative weight loss in bariatric surgery. Obes Surg. 2008;18(9):1059–61.
Becouarn G, Topart P, Ritz P. Weight loss prior to bariatric surgery is not a pre-requisite of excess weight loss outcomes in obese patients. Obes Surg. 2010;20:574–7.
Legenbauer T, De Zwaan M, Benecke A, et al. Depression and anxiety: their predictive function for weight loss in obese individuals. Obes Facts. 2009;2(4):227–34.
Averbukh Y, Heshka S, El-Shoreya H, et al. Depression score predicts weight loss following Roux-en-Y gastric bypass. Obes Surg. 2003;13(6):833–6.
Chau WY, Schmidt HJ, Kouli W, et al. Patient characteristics impacting excess weight loss following laparoscopic adjustable gastric banding. Obes Surg. 2005;15(3):346–50.
Ma Y, Pagoto SL, Olendzki BC, et al. Predictors of weight status following laparoscopic gastric bypass. Obes Surg. 2006;16(9):1227–31.
Våge V, Gjesdal CG, Eide GE, et al. Bone mineral density in females after jejunoileal bypass: a 25-year follow-up study. Obes Surg. 2004;14(3):305–12.
Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17(5):565–8.
Karlsson J, Taft C, Ryden A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond). 2007;31(8):1248–61.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122(3):248–256.e5.
Biorserud C, Olbers T, Fagevik Olsen M. Patients’ experience of surplus skin after laparoscopic gastric bypass. Obes Surg. 2011;21(3):273–7.
Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion: two decades of experience. In: Deitel M, Cowan GSM, editors. Update: surgery for the morbidly obese patient. Toronto: FD-Communications Inc.; 2000. p. 227–58.
Solhaug JH, Bassoe HH. Jejuno-ileal bypass operation for the treatment of morbid obesity. Short- and long-term consequences analysed in a follow-up study of 36 patients. Scand J Gastroenterol. 1979;14(5):535–43.
Arunabh S, Pollack S, Yeh J, et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88(1):157–61.
Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–3.
Holecki M, Zahorska-Markiewicz B, Chudek J, et al. Changes in bone mineral density and bone turnover markers in obese women after short-term weight loss therapy during a 5-year follow-up. Pol Arch Med Wewn. 2010;120(7–8):248–54.
Andersen JR, Aasprang A, Bergsholm P, et al. Anxiety and depression in association with morbid obesity: changes with improved physical health after duodenal switch. Health Qual Life Outcomes. 2010;8:52.
Våge V, Solhaug JH, Berstad A, et al. Jejunoileal bypass in the treatment of morbid obesity: a 25-year follow-up study of 36 patients. Obes Surg. 2002;12(3):312–8.
Acknowledgments
We acknowledge Drs. Nicola Scopinaro, Douglas Hess, Picard Marceau, and Aniceto Baltasar for valuable discussions and advices on bariatric surgery in general and BPD in special.
Disclosure
The first author had travel expenses for one international conference in 2010 covered by Covidien Norway through an educational grant given to the Surgical Department, Unit for Bariatric Surgery, Førde Central Hospital.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Våge, V., Gåsdal, R., Laukeland, C. et al. The Biliopancreatic Diversion with a Duodenal Switch (BPDDS): How Is It Optimally Performed?. OBES SURG 21, 1864–1869 (2011). https://doi.org/10.1007/s11695-011-0496-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-011-0496-9